Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-27T22:01:31.920Z Has data issue: false hasContentIssue false

Pharmacological profile of the 5-hydroxytryptamine receptor of Fasciola hepatica body wall muscle

Published online by Cambridge University Press:  06 April 2009

E. A. Tembe
Affiliation:
Department of Physiology and Pharmacology, University of Southampton, Bassett Crescent East, Southampton SO9 3TU
L. Holden-Dye*
Affiliation:
Department of Physiology and Pharmacology, University of Southampton, Bassett Crescent East, Southampton SO9 3TU
S. W. G. Smith
Affiliation:
Cambridge Animal and Public Health Ltd, Chesterford Park Research Station, Saffron Walden, Essex
P. A. M. Jacques
Affiliation:
Cambridge Animal and Public Health Ltd, Chesterford Park Research Station, Saffron Walden, Essex
R. J. Walker
Affiliation:
Department of Physiology and Pharmacology, University of Southampton, Bassett Crescent East, Southampton SO9 3TU
*
*Dr L. Holden-Dye, Department of Physiology and Pharmacology, University of Southampton, Bassett Crescent East, Southampton SO9 3TU

Summary

5-HT is a candidate for the excitatory transmitter at the neuromuscular junction in trematodes including Fasciola hepatica. This study has determined the response of a muscle strip preparation from Fasciola hepatica to 5-HT and a range of agonists that distinguish between the vertebrate receptor 5-HT subtypes. 5-HT increased the resting tone and the rhythmic activity of the muscle strip. Of the 19 compounds tested, only 10 had an effect similar to 5-HT and all but 2 of these were tryptamine compounds. 5-HT was more potent than tryptamine whilst 4-OH-tryptamine had no effect, suggesting that the response is mediated by a 5-HT rather than a tryptamine receptor. 5-Fluorotryptamine and 5-carboxyamidotryptamine were the most potent agonists. 8-OH-DPAT also mimicked the effect of 5-HT, though less potently. Assuming that these agents elicit their response through a common receptor, this suggests the presence of a 5-HT receptor with similar properties in terms of agonist recognition as the vertebrate 5-HT1 class of receptor involved in controlling Fasciola muscle motility.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Beernink, K. D., Nelson, S. D. & Mansour, T. E. (1963). Effect of lysergic acid derivatives on the liver fluke, Fasciola hepatica. International Journal of Neuropharmacology 2, 105–12.CrossRefGoogle Scholar
Berridge, M. J. (1972). The mode of action of 5-hydroxytryptamine. Journal of Experimental Biology 56, 311–21.CrossRefGoogle ScholarPubMed
Boyd, P. J., Gardner, C. R. & Walker, R. J. (1985). Actions of some 5-hydroxytryptamine analogues on the isolated heart of the snail, Helix aspersa. Comparative Biochemistry and Physiology 81C, 233–9.Google Scholar
Cadogan, A. & Humphrey, P. P. A. (1991). Classification of the 5-HT receptor mediating cardio-excitation in the snail, Helix aspersa. British Journal of Pharmacology 102, 97P.Google Scholar
Chaudhuri, J. & Donahue, M. J. (1989). Serotonin receptors in the tissues of adult Ascaris suum. Molecular and Biochemical Parasitology 35, 191–8.CrossRefGoogle ScholarPubMed
Donahue, M. J., Yacoub, N. J., Michenoff, C. A., Masaroncia, M. & Harris, B. G. (1981). Serotonin (5-hydroxytryptamine): a possible regulator of glycogenolysis in perfused muscle segments of Ascaris suum. Biochemical and Biophysical Research Communications 101, 112–17.CrossRefGoogle ScholarPubMed
Fairweather, I., Maule, A. G., Mitchell, S. H., Johnston, C. F. & Halton, D. W. (1987). Immunocytochemical demonstration of 5-hydroxytryptamine (serotonin) in the neurones and tissues of the liver fluke, Fasciola hepatica (Trematoda, Digenea). Parasitology Research 73, 255–8.CrossRefGoogle Scholar
Fetterer, R. H., Pax, R. A. & Bennett, J. L. (1977). Schistosoma mansoni: direct method for simultaneous recording of electrical and motor activity. Experimental Parasitology 43, 286–94.CrossRefGoogle ScholarPubMed
Fozard, J. R. (1987). 5-HT: the Enigma Variations. Trends in Pharmacological Science 8, 501–6.CrossRefGoogle Scholar
Greenberg, M. J. (1960). Structure-activity relationship of tryptamine analogues on the heart of Venus mercenaria. British Journal of Pharmacology 15, 375–88.Google ScholarPubMed
Holmes, S. D. & Fairweather, I. (1984). Fasciola hepatica: the effects of neuropharmacological agents upon in vitro motility. Experimental Parasitology 58, 194208.CrossRefGoogle ScholarPubMed
McNall, S. J. & Mansour, T. E. (1984). Novel serotonin receptors in Fasciola: characterization by studies on adenylate cyclase activation and 3H LSD binding. Biochemical Pharmacology 33, 2789–97.CrossRefGoogle ScholarPubMed
Maddrell, S. H. P., Pilcher, D. E. M. & Gardiner, B. O. C. (1971). Pharmacology of the Malpighian tubles of Rhodnius and Carausius: the structure-activity relationship of tryptamine analogues and the role of cAMP. Journal of Experimental Biology 54, 779804.CrossRefGoogle Scholar
Mansour, T. E. (1957). The effect of lysergic acid diethylamide, 5-hydroxytryptamine, and related compounds in the liver fluke, Fasciola hepatica. British Journal of Pharmacology 12, 406–9.Google ScholarPubMed
Mansour, T. E. (1964). The pharmacology and biochemistry of parasitic helminths. Advances in Pharmacology 3, 129–65.CrossRefGoogle ScholarPubMed
Mansour, T. E. (1984). Serotonin receptors in parasitic worms. Advances in Parasitology 23, 136.Google ScholarPubMed
Mansour, T. E., Lago, A. D. & Hawkins, J. L. (1957). Occurrence and possible role of serotonin in Fasciola hepatica. Federation Proceedings 16, 319.Google Scholar
Northup, J. K. & Mansour, T. E. (1978). Adenylate cyclase from Fasciola hepatica. I. Ligand specificity of adenylate cyclase-coupled serotonin receptors. Molecular Pharmacology 14, 804–19.Google ScholarPubMed
Pax, R. A. & Bennett, J. L. (1991). Neurobiology of parasitic platyhelminths: possible solutions to the problems of correlating structure with function. Parasitology 102, S31–S39.CrossRefGoogle Scholar
Peroutka, S. J. (1990). 5-Hydroxytryptamine receptor subtypes. Pharmacology and Toxicology 67, 373–83.CrossRefGoogle ScholarPubMed
Smith, P. A. & Walker, R. J. (1974). The action of 5-hydroxytryptamine and related compounds on the activity of Retzius cells of the leech, Hirudo medicinalis. British Journal of Pharmacology 51, 21–7.CrossRefGoogle ScholarPubMed
Sukhdeo, S. C. & Sukhdeo, M. K. (1988). Immunocytochemical and electrochemical detection of serotonin in neurones of Fasciola hepatica, a parasitic flatworm. Brain Research 463, 5762.CrossRefGoogle Scholar
Twarog, B. M. & Cole, R. A. (1972). Relaxation of catch in a molluscan smooth muscle. III. Effects of serotonin, dopamine and related compounds. Comparative Biochemistry and Physiology A A43, 331–5.CrossRefGoogle Scholar
Vehovszky, A. & Walker, R. J. (1991). An analysis of the 5-hydroxytryptamine (serotonin) receptor subtypes of central neurones of Helix aspersa. Comparative Biochemistry and Physiology, C 100, 463–76.CrossRefGoogle ScholarPubMed
Walker, R. J. (1985). The pharmacology of serotonin receptors in invertebrates. In Neuropharmacology of Serotonin (ed. Green, A. R.), pp. 366408. Oxford: Oxford University Press.Google Scholar
Walker, R. J. (1986). Transmitters and modulators. In The Mollusca, vol. 9, Neurobiology and Behaviour, Part 2 (ed. Willows, A. O. D.), pp. 279485. Orlando, USA: Academic Press.Google Scholar
Walker, R. J. & Vehovszky, A. (1990). 5-Hydroxytryptamine (5-HT) receptor subtypes in invertebrates. In Serotonin: From Cell Biology to Pharmacology and Therapeutics, (ed. Paoletti, R., Vanhoutte, P. M., Brunello, N. & Maggi, F. M.), pp. 283–8. Dordrecht, Netherlands: Kluwer Academic Publishers.CrossRefGoogle Scholar